Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma

Paul Windisch; Manuel Röhrich; Sebastian Regnery; Eric Tonndorf‐Martini; Thomas Held; Kristin Lang; Denise Bernhardt; Stefan Rieken; Frederik L. Giesel; Uwe Haberkorn; Jürgen Debus; Sebastian Adeberg

doi:10.1016/j.radonc.2020.06.040

Fibroblast Activation Protein (FAP) specific PET for advanced target volume delineation in glioblastoma

Paul Windisch(Heidelberg University), Manuel Röhrich(Heidelberg University), Sebastian Regnery(Heidelberg University), Eric Tonndorf‐Martini(Heidelberg University), Thomas Held(Heidelberg University), Kristin Lang(Heidelberg University), Denise Bernhardt(Heidelberg University), Stefan Rieken(Heidelberg University), Frederik L. Giesel(Heidelberg University), Uwe Haberkorn(German Cancer Research Center), Jürgen Debus(German Cancer Research Center), Sebastian Adeberg(German Cancer Research Center)

Radiotherapy and Oncology

June 27, 2020

10.1016/j.radonc.2020.06.040

Cited by 63Open Access

Full Text

Abstract

Fibroblast Activation Protein (FAP)-specific Positron Emission Tomography (PET) has shown promising results in various cancers. This pilot study compares FAP-specific PET to MRI for treatment planning in 13 Glioblastoma patients. The resulting incongruent volumes could provide additional information for radiotherapy or biopsy planning.

Related Papers

No related papers found

Powered by citation graph analysis